Vertex Pharmaceuticals VRTX-1.68 % decrease; red down pointing triangle has fallen out of favor with Wall Street, but that gloomy backdrop might be just the opportunity potential investors needed.

Back in 2012, Vertex Pharmaceuticals changed thousands of lives when it won approval to market Kalydeco to treat cystic fibrosis patients in the U.S. and EU. Cystic fibrosis, or CF, can be caused ...

Urban Heat Resurrects Synth-Pop With Towering Debut LP The Tower is a grand-scale monument to the overindulgence of Eighties New Wave Reviewed by Cy White, Fri., Aug. 16, 2024 ...

The proliferation of digital modeling of analog synths has lowered the barrier for cash-strapped, would-be musicians hoping to become the next big synth group like S U R V I V E (the band ...

With two new correctors entering clinical development, Vertex is about to leave Galapagos and Concert in the dust. S&P 500 +---% | Stock Advisor +---% Join The Motley Fool. Accessibility ...